Clinical Research Directory
Browse clinical research sites, groups, and studies.
Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
Sponsor: West China Hospital
Summary
To evaluate the efficacy and safety of Spirulina-Derived Product for prevention and treatment of oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors.
Official title: Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-06-27
Completion Date
2026-04-30
Last Updated
2026-04-07
Healthy Volunteers
No
Conditions
Interventions
Spray of spirulina derivatives
An oral spray formulated with purified spirulina-derived exosomes.
Spray of placebo
The placebo oral spray will be formulated with inactive ingredients matched in appearance and flavor profile to the active spirulina-derived product.
Radiotherapy
One of the inclusion criteria for the study was that patients with squamous carcinoma of the head and neck (including nasopharyngeal carcinoma) needed to receive either radiotherapy alone or simultaneous radiotherapy and chemotherapy.
Locations (1)
West China Hospital, Sichuan University
Chengdu, Sichuan, China